Home / PDA Letter / Full Article

Response to "Standing Guard"

by Kevin L. Williams, bioMérieux

Published On Jan 28, 2019

The article “Standing Guard” was published on the PDA Letter website Sept. 26. This response addresses what we consider misleading conclusions within the article. As manufacturers of recombinant Factor C (rFC) endotoxin detection assays—known as the bioMérieux ENDONEXT™ family of products, we are committed to providing an accurate portrayal of the emerging limulus amebocyte lysate (LAL) replacement reagent rFC.

The contents of "Response to "Standing Guard"" are available to PDA members. Please sign up or log in to read the full article.